Investor relations

# A disciplined path from pipeline to patients

A focused, late-stage pipeline, a clear registration strategy and a team with a proven track record — here's what we're building for shareholders.

View investor presentation → Latest news

Stock information

## Zentia Therapeutics (NASDAQ: ZNTA)

Market data shown as of last market close. Placeholder values for demonstration.

Share price $0.00 ▲ +1.8% today
Market cap $2.1B ▲ 52-week high
Volume 1.4M Avg 30-day
52-week range $18.20–39.75 High / low

Investor presentation

## The Zentia story in one deck

Corporate presentation

### Corporate Presentation — Q3 2026

The science behind Zent-001, our late-stage clinical data, the market opportunity and our path to registration.

Updated August 2026 · 28 slides Includes full pipeline overview and financial position

Download the latest presentation and quarterly update.

Governance

## Corporate governance

Independent oversight and transparent practices.

B
Board of Directors Independent, majority-led oversight
A
Audit Committee Financial reporting & controls
C
Compensation Committee Executive compensation oversight
N
Nominating & Governance Committee Board composition & ethics

SEC filings

## Filings & documents

Quarterly Report on Form 10-Q Q2 2026 · Filed August 2026
→
Annual Report on Form 10-K Fiscal year 2025 · Filed February 2026
→
Proxy Statement Annual meeting of stockholders · 2026
→
Code of Business Conduct & Ethics Adopted 2023
→

Resources

## IR resources & alerts

Subscribe to email alerts and access frequently used investor tools.

Email alerts Get quarterly results and press releases
→
Investor FAQ Common questions about Zentia
→
Contact investor relations investors@zentia-therapeutics.com
→